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Abstract
Background: Value-based health care is increasingly used to facilitate a sys-
tematic approach during follow-up of patients. We developed Healthcare Mon-
itor (HM): a structure of electronic patient-reported outcome measures
(ePROs) for the longitudinal follow-up of head and neck cancer (HNC)
patients. This study shares key lessons from implementation and seeks to pro-
vide insight into how patients experience HM.
Methods: We conducted a mixed-methods study using quantitative data from a
nonrandomized retrospective survey of patients who received HM (n = 45) vs
standard care (n = 46) and qualitative data from structured interviews (n = 15).
Results: Implementation of HM included significant challenges. Finding com-
mon ground among clinicians, administrators, and IT staff was most impor-
tant. Qualitative findings suggest that patients experienced better doctor-
patient communication and increased efficiency of the consultation using
HM. Patients felt better prepared and experienced more focus on critical issues.
Quantitative analysis did not show significant differences.
Conclusions: Integration of HM into routine care for HNC patients may have
increased patient-centered care and facilitated screening of symptoms. How-
ever, future research is needed to analyze the potential benefits more
extensively.
KEYWORD S
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1 | INTRODUCTION
Value-based health care is increasingly used to stimulate
patient-centered care and to empower patients during
doctor-patient encounters.1-3 This concept, which was
first described by Michael Porter, claims that improve-
ment in both quality and cost of care can be achieved by
understanding and integrating the patient perspective
into care.2 To help clinicians better understand the
patient perspective, use of patient-reported outcome
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measurements (PROMs) is recognized as essential.3 They
are defined as standardized, validated questionnaires
completed by patients to measure their perception of
their functional well-being and health status.4 Electronic
PROMs (ePROs) allow for efficient standardized assess-
ment and improved ease of use in comparison with
paper-based PROMs.4-6
Understanding the patient's perspective is important
during follow-up of patients with cancer, since doctor-
patient communication can be challenging for both
patients and doctors. Patients can have difficulties shar-
ing a complete health status in a short period of time and
doctors also need to have good skills to facilitate this pro-
cess.7,8 Physical impairments and psychosocial problems
may go undetected and opportunities to intervene can be
missed.9,10 By using ePROs, patients might actively par-
ticipate in their own care and clinicians identify critical
issues, improving patient management.4,6,9,11-14
ePROs focus on physical problems, psychosocial prob-
lems, and/or the impact on global health-related quality of
life (HRQoL).4 They provide data detailing the patient's
own view on the impact of having cancer and its treatment.
Furthermore, ePROs can capture a more holistic view on
individual health outcomes. There is evidence from general
cancer care that clinical interventions following the routine
use of ePROs in clinical practice may improve patients'
HRQoL, enhance doctor-patient communication, and may
even lengthen survival, for example, among patients with
advanced cancers.1,12 ePROs can also play a role in shared
decision making.15,16 However, monitoring of ePROs alone
does not improve patients' outcomes.8,17,18 Providing indi-
vidual feedback to the patient can help to, for example, dis-
cuss the need for supportive care.4,19-21
The ePRO approach is also getting more attention in
head and neck cancer (HNC) care.22,23 Due to advance-
ments in diagnosis and treatment, the number of HNC
survivors have increased.24 However, HNC patients often
have to deal with treatment-related side effects that can
have an enormous impact on patients' daily life. Some of
these side-effects are immediately noticeable in social set-
tings and can negatively affect HRQoL and increase
levels of psychological distress and on the spousal rela-
tionship.25-27 ePROs might support patients in coping
with the physical and emotional challenges of HNC by
providing themselves and their clinicians better insight
into their condition.
In 2013, we developed Healthcare Monitor (HM), an
ePRO-based clinical support system, which uses simple
and internationally validated questionnaires regarding
HNC to measure physical and psychosocial functioning
from day of diagnosis until 5 years after. Since 2015, HM
has been structurally embedded in our care for HNC
patients.
The overall aim of this study was to provide a first
evaluation of HM after implementation. We first review
the challenges we experienced during the initial imple-
mentation phase (ie, clinical impressions). In addition,
we then evaluate patients' experiences with HM in prac-
tice and the perceptions of quality of care among patients
receiving standard care vs those receiving HM care.
2 | MATERIALS AND METHODS
2.1 | HM: description and organizational
setting
The Erasmus Medical Center (Erasmus MC) houses the
largest HNC center in the Netherlands with over 600 new
patients annually. In 2013, we developed Healthcare
Monitor (HM) (see Figure 1). This is an ePRO-based clin-
ical support system, designed with health care profes-
sionals and technology providers for follow-up and
management of HNC patients. Our vision behind the
development of HM is threefold:
1. improve overall quality of patientcare,
2. support research in general,
3. improve transparency of health care for the purpose
of national registries and audits.
Internationally validated questionnaires (Table 1),28-34
measuring physical problems, psychosocial symptoms,
and HRQoL of HNC patients, are routinely collected with
HM from the first visit at the day of diagnosis to the final
consultation (5 years after end of treatment). A dedicated
nurse practitioner counsels patients on the way of working
with HM. Patients suffering from disorders affecting cogni-
tive abilities (eg, dementia, Korsakoff syndrome) may be
excluded from participation in HM. All patients complete
questionnaires before every outpatient clinic visit. They do
this either in the comfort of home via Internet or with an
iPad at the clinic. In case patients want assistance with fill-
ing out the questionnaires, for example, due to illiteracy,
trained volunteers are available to help. These volunteers
are already part of our specialized outpatient clinic team
for HNC patients. They help patients with the logistic pro-
cedures during diagnosis.
Clinicians have real-time access to the results that are
graphically displayed inside the electronic health record
(EHR). Clear graphics help to systematically monitor
symptoms and allow clinicians to compare individual
patient results during the course of time and with their
peer group. Firstly, published norms from questionnaires
(Table 1) were used as peer group information.28-32 Since
2018, we also evaluate scores from all other HNC patients
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treated at Erasmus MC as the amount of data is becom-
ing sufficient to make a valid comparison from that time
onwards. Scores from HNC patients evaluated at the
same point in posttreatment follow-up care, with the
same tumor type and stage are used for this purpose.
The literature shows us that monitoring of symptoms
alone is not enough.35 Our HM concept therefore
includes both monitoring and sharing the results with
patients. Clinicians use graphs to provide direct individ-
ual feedback to each patient. All patients receive further
clinical or diagnostic evaluation or referral to specialty
care as needed. HM data and the conversation following
the individual feedback can thus further guide health
care providers and patients on supportive care needs.
Patients' informed consent to use their data for peer
group information and for broader research and
benchmark purposes is requested before and after treat-
ment. Since the time between diagnosis and first regular
follow-up visit after treatment can easily reach up to
6 months, we believe it is more conscientious to ask
patients again for their consent after treatment.
We started HM with a pilot phase from November
2013 to March 2015 among 260 patients with small (T1-2)
laryngeal carcinoma, treated with (laser) surgery. Patients
were included at any point during their diagnostic, treat-
ment or posttreatment trajectory (up to 5 years after diag-
nosis). Total response was 97% at intake and 90% in
follow-up phase. As a first (nonscientific) evaluation,
these patients were asked after their visit at the out-
patient clinic if they thought HM to be an improvement
of care and 70% agreed. Physicians also found HM an
useful tool to respond better to patients' needs. After con-
cluding the initial pilot phase, HM has been structurally
embedded in our care for HNC patients since April 2015.
2.2 | First evaluation of HM: key lessons
and mixed-methods design
In the current report, we review the challenges we experi-
enced during the initial implementation phase by sharing
barriers and facilitators based on pragmatic experience in
implementing HM initiative. Some of these impressions
are briefly summarized in narrative and tabular form in
the beginning of Section 3. In addition, to evaluate
patient experiences, we conducted a mixed-methods
study using quantitative data from a self-developed
patient-reported experience measures (PREM) question-
naire and qualitative data from interviews. Ethical
FIGURE 1 Infographic Healthcare Monitor
TABLE 1 Generic and specific patient-reported outcome
measurements used in Healthcare Monitor
General questionnaire: items on lifestyle, socioeconomic status,
and civil status
EORTC QLQ-C30: assesses the quality of life of patients with
cancer
EORTC H&N35 module: measures the quality of life
specifically in patients with head and neck cancer
Hospital Anxiety and Depression Scale (HADS): measures
symptoms of anxiety and depression in patients
Eating Assessment Tool (EAT10): assesses swallowing function
Voice Handicap Index (VHI): assesses function of voice and
speech
EQ5D-3L: generic standardized measure of health status
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approval was not necessary according to the Dutch Medi-
cal Research Involving Human Subjects Act, as this study
evaluated standard care.
2.2.1 | Quantitative method
We invited n = 151 patients diagnosed with HNC
between October 2014 and April 2016 to anonymously
complete a survey on the care they received during
follow-up visits at our outpatient clinic. This number of
patients invited was not based on a power analysis, but
was determined by the number of patients actively using
HM at that time. In the accompanying letter provided to
patients, informed consent was requested to use the data
anonymously for the purpose of this evaluation study.
There was no overlap in participants between the pilot
phase and this evaluation study.
Two groups were distinguished: (a) HNC patients that
were diagnosed prior to implementation of HM (standard
care group), and (b) HNC patients that were diagnosed after
implementation of HM (HM care group). Patients in group
2 were treated more recently than those in group 1. No
other patient characteristics than age and gender were
available due to the anonymous response. In the standard
care group symptoms were discussed during standard clini-
cal encounters. In the HM care group, patients filled out
ePRO questionnaires before their doctors visit and the
results were directly discussed during the consultation.
We developed a 12-item PREM questionnaire with a
4-point Likert scale for both groups of patients. Six extra
items were developed specifically for the HM care group,
based on questions on functioning of HM raised in our
research meetings and meetings with health care profes-
sionals. In this survey for HM patients (supplementary
Table 1a), we asked about the burden of filling out HM
questionnaires and about the congruity of items addressed
in HM and experienced by patients themselves. Both groups
of patients were asked to answer questions on doctor-
patient communication, their preparation to discuss their
individual conditions, physicians' awareness of individual
patient conditions and efforts made to improve these indi-
vidual patient conditions (supplementary Table 1b). We
also asked questions about the length of the consultation
and asked patients to rate their subjectively experienced
quality of care ranging between 1 and 10. A higher score
means a higher experienced level of quality of care.
2.2.2 | Qualitative method
Structured interviews (N = 15) were conducted in 2016
during one full consultation day of one HNC surgeon at
the outpatient clinic. Only patients who received HM care
and were in the early follow-up phase, several months
after curative treatment, were approached to take part in
the interviews. Patients were selected randomly from phy-
sician's consultation visits at our outpatient clinic. The
interviews were held by a female senior researcher with
PhD degree (MO). There was no relationship established
with participants prior to start of the interview, nor did
participants have knowledge of the interview. Interviews
were held either directly after the consultation with the
HNC surgeon or after the moment patients filled in the
HM ePROs at our outpatient clinic prior to the visit with
their HNC surgeon. All interviews were held at the outpa-
tient clinic of the Erasmus Medical Center. All approached
patients agreed to cooperate with the interview, and they
gave oral informed consent to use the interview for the
purpose of this evaluation study. Patients were interviewed
on the added value of HM and on how they think of HM
in general. A semi-structured interview guide was made
which consisted five key questions, all with an open char-
acter, followed by more elaborate questions to follow-
through on the subject (Table 2). The questions were
asked in a fixed order for all the interviews.
2.2.3 | Data analyses
All statistical analyses were performed using SPSS version
22 (IBM Corp. Armonk, NY). The quantitative data from
the nonrandomized retrospective survey were analyzed
using descriptive statistics. To compare patients in the HM
care group to those in the standard care group on items 1-7
of the PREM questionnaire, statistical analysis of categorical
data was performed by chi-square test and analysis of con-
tinuous data by Students' t-test. Only four patients in the
standard care group did not fill out the complete survey.
Since these data were missing not at random, we left the
data out of the analysis by performing a complete case
TABLE 2 Interview guide for structured interviews
1. What are your general experiences with “Healthcare
Monitor”?
2. Do you find the way of working with “Healthcare Monitor” a
good thing? And if so or not, why?
3. “Healthcare Monitor” provides your doctor with direct
insight into you symptoms. What is your opinion about this?
4. Do you experience added value by filling health care
questionnaires upfront to your doctor s control visit? If so,
what is the added value in your opinion?
5. Do you have any suggestions for us to further improve our
working method with Healthcare Monitor?
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analysis. Logistic regression analysis, adjusted for age and
gender, was performed to analyze differences in experienced
quality of care (items 8-12) between HM care and standard
care. The answers that patients provided on the 4-point
Likert scale were dichotomized to “agree” and “disagree” for
this purpose. P-values of <.05 were considered significant.
The semi-structured interviews were thematically
analyzed by a trained senior researcher with no relation-
ship with the patients (MO). Qualitative content analysis
was used for analysis of the data and inductive categories
were derived. Based on the answers provided by patients
during the interviews, three themes were identified from
the data and clearly presented in the results.
3 | RESULTS
3.1 | Key clinical impressions from the
setup and implementation of HM
The implementation of an ePRO structure in clinical
practice includes significant challenges.4,36,37 Our experi-
enced barriers and facilitators are summed up in Table 3.
First of all, common ground is needed. One must gain
support from every member of the team, including health
care providers, administrative employees, and technology
providers. This task will take some effort, but we believe the
common goal of improving patient caremakes it worthwhile.
We found conducting a pilot phase to be very helpful
in reducing any “teething problems.” As of January 2019,
1737 patients have taken part in HM from their day of
diagnosis and routinely receive this care, with 95%
patient compliance at intake and over 80% at the differ-
ent moments of follow-up.
In comparison with the literature regarding use of
PROs in oncology settings, our compliance rates are
uncommonly high.4 We believe that the way we integrated
ePROs in regular patient care leads to this high compli-
ance. Reported data of the patient are directly used for the
benefit of the patient, and the online system facilitates a
better preparation for clinical consultation given the
opportunity to fill out ePROs when it suits the patient.
Illiteracy, not having access to internet, and advanced
age are known barriers for participation of patients in an
ePRO structure.4,23 We chose to train our already avail-
able group of volunteers in assisting patients with filling
out HM questionnaires. This role is important for the sus-
tainability of HM since the volunteers encourage patients
to fill out the questionnaires themselves by showing the
ease of the system. An important group of vulnerable
patients who generally do not have access to digital solu-
tions and may have problems with phrasing their com-
plaints is thus supported to take part in HM care.
The graphical display of HM results inside the hospi-
tal information system is also helpful. The course of
symptoms can be identified and patients' individual
results can be compared with their peer group.
However, we also experienced that the implementa-
tion of HM consumes time and energy. Organizational
and workplace adjustments were necessary, and the close
cooperation with health care and technology providers
was essential. For example, all medical staff (including
secretaries, nurses, doctors, and case managers) was
trained in using and/or interpreting HM. A small
TABLE 3 Facilitators and barriers for implementation of
“Healthcare Monitor” care
Facilitators of “Healthcare Monitor”
• Patients can fill out the questionnaires via internet at the
comfort of their homes.
• Trained volunteers can assist patients with filling out the
questionnaires before the doctor's visit.
• Clinicians have real-time access to the results, which are
graphically displayed inside the hospital information system.
• Clinicians capture a holistic view of the patient including
both physical and psychosocial functioning.
• Review of longitudinal ePRO reports is possible to identify
the course of physical and psychosocial complaints and to
compare patients individual results with their peer group.
• Clinicians use the results to provide direct individual
feedback to the patient on the need for supportive care.
• Clinicians can identify critical issues earlier.
• Better counseling of patients is possible leading to better
quality of care.
• Patients can actively participate in their own care which
strengthens patient empowerment.
Barriers to use “Healthcare Monitor”
• The implementation of HM consumes time and energy while
the organization still runs all the other activities it has going.
• Dedication and support is needed from every member of
the team.
• For successful implementation, it takes effort to motivate all
health care providers, administrative employees, and
technology providers.
• Many workplace and organizational adjustments are
necessary.
• A sustainable and robust technical environment is necessary.
• Adequate resources are necessary so that patients who
screen positive subsequently will receive diagnostic or
clinical evaluation, and referral to specialty care as needed.
• The extra costs needed to implement HM care are not
reimbursed by health insurers or government yet.
• Evaluation of the work process as a whole is needed in order
to adapt user needs.
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TABLE 4 Perceptions of quality of care among patients receiving standard care vs those receiving electronic patient-reported symptom
monitoring
Standard care (n = 42) “Healthcare Monitor” (n = 45)
P valueaMean (SD)/frequency % Mean (SD)/frequency %
1 Age (years) 67.5 (11.3) 63.7 (9.7) .092
2 Gender Male 30 71.4 34 75.6% .740
Female 12 28.6% 11 24.4%
3 Did the doctor discuss your most common
health complaints?
Yes 37 88.1% 43 95.5% .636
No 5 11.9% 2 4.5%
4 Has the doctor taken action when it comes
to treating your complaints?
Yes 34 80.9% 41 91.1% .375
No 8 19.1% 4 8.9%
5 Did you miss topics during the
consultation?
Yes 12 28.6% 10 22.2% .243
No 30 71.4% 35 77.8%
5A Did you miss a topic on symptom burden
during the consultation?
Yes 34 81.0% 39 86.7% .286
No 8 19.0% 6 13.3%
5B Did you miss a topic on psychosocial
distress during the consultation?
Yes 37 88.1% 39 86.7% .621
No 5 11.9% 6 13.3%
5C Did you miss a topic on comorbidity during
the consultation?
Yes 40 95.2% 42 93.3% .662
No 2 4.8% 3 6.7%
5D Did you miss a topic on medication during
the consultation?
Yes 40 95.2% 42 93.3% .662
No 2 4.8% 3 6.7%
5E Did you miss a topic on influence of
disease on your partner during the
consultation?
Yes 37 88.1% 40 88.9% .748
No 5 11.9% 5 11.1%
5F Did you miss a topic on influence of
disease on your occupation during the
consultation?
Yes 39 92.9% 43 95.6% .645
No 3 7.1% 2 4.4%
5G Did you miss a topic on influence of
disease on your social life during the
consultation?
Yes 39 92.9% 40 88.9% .725
No 3 7.1% 5 11.1%
6 Subjective rating (1) to (10) of experienced
quality of care
8.2 (SD 1.3) 8.1 (SD 1.1) .695
7 Length of consultation (minutes) 12 (SD 6) 11 (SD 4) .149
8 I felt well prepared for the consultation
with my treating physician
Yes 41 97.6% 45 100% .458
No 0 0% 0 0%
Missing 1 2.4% 0 0%
9 My treating physician was focused on my
specific complaints
Yes 39 92.9% 42 93.3% .398
No 3 7.1% 2 4.4%
Missing 0 0% 1 2.3%
10 My treating physician had a complete
picture of me
Yes 30 71.4% 38 84.4% .554
No 8 19% 7 15.6%
Missing 4 9.6% 0 0%
11 My treating physician paid attention to my
specific complaints
Yes 37 88.1% 41 91.1% .291
No 5 11.9% 3 6.6%
Missing 0 0% 1 2.3%
(Continues)
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renovation of our outpatient clinic was necessary to have a
private space available for filling out HM questionnaires
on the iPad. Furthermore, after 2 years, we had to hire a
new secretary to manage the HM system working sched-
ules of the volunteer group and to oversee that every
patient fills in the HM questionnaires beforehand (either
at home or at the clinic). The provision of a powerful IT
network and the assurance of data safety was necessary in
order to facilitate a more efficient and safe work process.
3.1.1 | Quantitative results from the
mixed-methods study
Within the HM group, 45 of 71 patients (63.4%) completed
this survey, and 46 of 66 patients (69.7%) completed the sur-
vey in the standard care group. No information was avail-
able on reasons for declining participation. Both groups of
patients showed comparable distribution of age and gender.
Within the HM group, we found that 31 (69%) of patients
TABLE 4 (Continued)
Standard care (n = 42) “Healthcare Monitor” (n = 45)
P valueaMean (SD)/frequency % Mean (SD)/frequency %
12 My treating physician undertook action in
response to my specific complaints
Yes 33 78.6% 40 88.8% .585
No 4 9.5% 4 8.8%
Missing 5 11.9% 1 2.4%
aCategorical data analyzed by chi-square test, continuous data by Students' t-test, equal variances not assumed.
TABLE 5 Verbatim examples of three overall themes regarding patients' views of “Healthcare Monitor” experience in practice
Theme Verbatim examplea
Better preparation patient
Patients see HM as a tool to be better prepared
for their visit to the doctor. Patients forget less
and because they have been through all the
questions beforehand, they are more
conscious on how they really feel.
“This system makes it easier for us as a patient to come to the doctor,
because you have been through all the questions yourself.”
“If I did not have this preparation with the questionnaires when going
to my control visit, I would close the door after my consult thinking ´I
should have asked my doctor this or that!”
“It is good for me, as a patient, to fill out these questionnaires because I
need to think myself how I really feel, so that I can ask my doctor the
right questions.”
“You already shared upfront (with the questionnaires) how you are
doing”
Better doctor-patient communication
A good preparation to the doctor's visit
generally contributes to the quality of the
conversation and HM seems to play an
important role in that process. Patients
mentioned that the doctor can see at one
glance how they are doing. The fact that the
doctor has this complete overview of the
patient in advance, makes it easier for them
to speak to their doctor.
“When you fill out the questionnaires, I understand what the doctor
wants to know from me, so I do not feel overwhelmed by the doctor
as I know now what to expect.”
“It is good that the doctor has a complete overview of how I am doing
and how I cope with it.”
“You can be more efficient in your talk with the doctor and it might
result in shorter waiting times.”
“I do not have to think so hard anymore (how I am doing) during the
doctor's visit.”
Positive patient experience
The way of working with HM contributes to a
positive experience and a sense of security
and peace. Patients are feeling heard, taken
seriously, and they felt there is room to share
both their physical and mental complaints.
“By filling out the questionnaires I feel that the doctor looks at me in a
professional manner. There is a good overall control.”
“The doctor can directly follow through at my complaints and that is a
good thing.”
“It is a nice feeling that they pay attention to me.”
“I think the “Healthcare Monitor” is a good thing, especially sometime
after treatment, when you reflect on the whole trajectory and how
you feel about that.”
aAll quotes are based on responses from varied patients.
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completed the HM questionnaires at home, and 12 (27%)
used the help of a volunteer to complete the HM question-
naires at the outpatient clinic. The time needed to complete
HM questionnaires as perceived by patients was on average
19 minutes (SD 8 minutes). A majority of 41 patients
(91.1%) indicated that this time was not too short nor too
long. A minority of patients found the HM questionnaires
unclear (n = 2, 4%) and irrelevant (n = 2, 4%). The reasons
these patients mentioned were “they're asking me to
answer the same questions using different wording 20 times
in a row” and “I have to answer questions on pain manage-
ment that are not related to my tongue cancer.”
In univariate analysis, no significant differences on
any of the 17 items were seen between the two groups of
patients (Table 4). In comparison with standard care, more
patients indicated that the use of HM helped physicians to
have a more complete picture of patients and to have a
focus on their specific condition; however, these were non-
significant results. Also the length of the consultation as
perceived by patients was shorter when using HM, but this
was also not a significant difference. Logistic regression
analysis showed that age and gender were not significant
predictors for the experienced quality of care in both
groups (items 8-12). The subjectively overall experienced
quality of care (item 6) was equally high in both groups.
3.1.2 | Qualitative results from the
mixed-methods study
The answers provided by patients during the interviews
were categorized into three themes. The themes are
(a) patient preparation for the consultation, (b) doctor-
patient communication, and (c) patient experience with
HM care. A summary of the results including verbatim
examples are provided in Table 5. Patients also shared
their views of the pros and cons of HM and suggestions
for improvement. (Table 6).
4 | DISCUSSION
The overall aim of this study was to provide insight into
our key lessons on the set-up and implementation of HM
and into how HNC patients experience and value HM
care in clinical practice.
We believe that the implementation of HM included
significant challenges and also had demonstrated to be a
TABLE 6 Patient perceptions of pros and cons of Healthcare Monitor and suggestions for improvement, from the structured interviews
Pros Cons
• I experience a more efficient doctors visit
• I love to fill out the questionnaires: it is easy and quick, so
I am happy with it
• The Healthcare Monitor gives me insight in how I
really feel
• I feel much better prepared!
• A big advantage is that I can fill outthe questionnaires at
home via internet
• I feel a greater commitment of my doctor in this way
• I feel at ease with the help of a volunteer at the hospital
when filling out the questionnaires
• It is very well organized in comparison to other hospitals
• It is a fuss: so many questionnaires
• Questionnaires sometimes look alike
• Every time when I fill out the questionnaires, I feel
confronted with the disease I had…
Suggestions for improvement
• It is important to emphasize that the “Healthcare Monitor” is beneficial for you as an individual patient.
• Would be better if questions are not only related to the last week, however, to the period in between the control visits.
TABLE 7 Toolkit: with eight essential questions toward
implementation of an ePRO structure in HNC clinics
Step 1: “Why do I want to measure outcome in this patient
group?”
Step 2: “What are the right outcomes measures for this patient
group?”
Step 3: “What questionnaires should I use, are those validated
and readily available?”
Step 4: “What are the right moments to measure ePROs?”
Step 5: “Are there any workspace or organizational adjustments
necessary?”
Step 6: “How do I take data-integrity into account?”
Step 7: “What will I do with the obtained data?”
Step 8: “Do I have adequate resources available for patients in
need of extra care?”
Abbreviations: ePROs, electronic patient-reported outcome mea-
sures; HNC, head and neck cancer.
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worthwhile investment. The results of the qualitative
analyses look very promising. However, the quantitative
analyses did not show any significant results. Quantita-
tive analyses showed that HM users scored higher on
some questions of the PREM questionnaire than those
who had received standard care. HM users experienced
more often that their physician had a complete picture of
them and undertook action in response to their specific
complaints. The differences in these percentages were
not statistically significant but they exceeded 10 points
and thus appear to be clinically meaningful results wor-
thy of further research. No significant difference regard-
ing the perceived quality of care could be found between
groups possibly because of a ceiling effect. Also, the stan-
dard care patients were further along in their recovery
than patients in the HM group, and this might have
introduced confounding by time since treatment.
Qualitative analyses suggested that HNC patients
who received HM care noticed more focus on critical
issues and an increased efficiency of the consultation.
Patients felt better prepared and were more conscious on
how they really feel, and mentioned their clinicians had
a more holistic view on their symptoms. Furthermore,
structurally monitoring ePROs and discussing the results
with individual patients contributed to a positive experi-
ence and a sense of security. These qualitative findings
are in line with earlier (both qualitative and quantitative)
studies on the value of using PROMs in HNC clinical
practice to improve communication between doctors and
patients and to facilitate screening of symptoms and psy-
chological distress.16,22,23,35 In our study, HNC patients
also experienced a better doctor-patient communication
with HM.
The results from our evaluation indicate that HM
might be useful in identifying the latent needs of patients.
The ePRO questions stimulate patients to think about
issues in relation to their disease they might not have
thought about before. As a result, awareness of symptoms
and a sense of the normal course of disease can be raised,
leading to patient empowerment.
Besides the improvement of perceived patient care as
suggested by the qualitative results, we learned that con-
ducting scientific studies can benefit from the existing
ePRO structure within HM as well. The logistic set-up,
including organizational and workplace adjustments, and
the relationship of trust between patients and trained vol-
unteers, creates opportunities to counsel patients on
research projects. Longitudinal ePRO data can enhance
benchmarking on an individual level in our clinic as well
as in larger, multicenter, studies.
We would like to share our lessons with other HNC
clinics, in order to improve patient care and create
benchmark possibilities. Therefore, we prepared a
guideline with eight questions that might be helpful to
address before implementing an ePRO structure into
daily clinical practice (see Table 7).
4.1 | Future perspectives
Although we experienced that the implementation of
HM took a lot of effort, the experienced value made it
worthwhile. This positive balance contributed to a sus-
tainable system. In order to maintain this balance, we
believe two areas of focus for the future are important.
One way of achieving a lower experienced effort
might be by exploring computer adaptive testing methods
(CAT) in HM, since the use of traditional PROMs often
requires patients to answer items that are not directly
applicable to them.38,39 CAT has several advantages
including reduced patient burden and increased question
relevance to individual patients.40 Another way HM
might be improved is the optimization of the graphical
display of the results. We are currently developing a
dashboard including HM results, which can help physi-
cians to efficiently get an overview of all data. In order to
achieve a higher experienced value, research is needed to
obtain more insight into the referral and uptake of sup-
portive care services following the individual feedback
from doctors to patients using HM.
An ePRO setup such as HM may also have direct
influence on health care costs. On the one hand, one
can imagine that when more symptoms (eg, psychoso-
cial) are being recognized due to HM, this will also lead
to more diagnostics or involvement of other health care
providers (eg, psychiatrist), and therefore probably to
higher costs. On the other hand, HM could also contrib-
ute to lower rather than higher costs due to earlier iden-
tification of conditions and reduced frequency of regular
outpatient clinic visits. A cost-effectiveness study seems
appropriate, especially in the context of value-based
health care.
4.2 | Study limitations
The mixed-methods design we used for this study was
sufficient as a first step and forms a useful foundation for
further research.
However, this study has some limitations. Both the
structured interviews and the retrospective non-
randomized survey have a small sample size. Although
the questions of the structured interview all have an open
character, they may have introduced a positive bias as
some of the questions already include the suggestion of
HM being beneficial. The small sample size of the
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quantitative analysis and absence of a power analysis
might explain the nonsignificant results. Also, clinical
characteristics or demographic variables other than age
and gender were not available.
Another limitation of this study is that we did not
evaluate the experience of health care providers on the
use of HM. Therefore, we are currently preparing a yearly
evaluation questionnaire for patients and professionals.
5 | CONCLUSION
Our qualitative data suggest that integration of our ePRO
clinical support system Healthcare Monitor into routine
care for HNC patients may lead to increased patient-
centered care and an improved perception of doctor-
patient communication, and may enable a holistic
approach, and enhance patient empowerment.
Structurally monitoring ePROs and discussing the
results with each patient appears to contribute to a posi-
tive patient experience and facilitates screening and
follow-up of symptoms including psychological distress.
However, future research is needed to analyze the poten-
tial benefits more extensively.
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SUPPORTING INFORMATION
Additional supporting information may be found online
in the Supporting Information section at the end of this
article.
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